1. Home
  2. SCLXW vs WTFCP Comparison

SCLXW vs WTFCP Comparison

Compare SCLXW & WTFCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLXW
  • WTFCP
  • Stock Information
  • Founded
  • SCLXW N/A
  • WTFCP N/A
  • Country
  • SCLXW United States
  • WTFCP United States
  • Employees
  • SCLXW 111
  • WTFCP 5903
  • Industry
  • SCLXW Biotechnology: Pharmaceutical Preparations
  • WTFCP Major Banks
  • Sector
  • SCLXW Health Care
  • WTFCP Finance
  • Exchange
  • SCLXW Nasdaq
  • WTFCP Nasdaq
  • Market Cap
  • SCLXW N/A
  • WTFCP N/A
  • IPO Year
  • SCLXW N/A
  • WTFCP N/A
  • Fundamental
  • Price
  • SCLXW $0.10
  • WTFCP $24.96
  • Analyst Decision
  • SCLXW
  • WTFCP
  • Analyst Count
  • SCLXW 0
  • WTFCP 0
  • Target Price
  • SCLXW N/A
  • WTFCP N/A
  • AVG Volume (30 Days)
  • SCLXW 4.0K
  • WTFCP N/A
  • Earning Date
  • SCLXW 03-07-2025
  • WTFCP N/A
  • Dividend Yield
  • SCLXW N/A
  • WTFCP N/A
  • EPS Growth
  • SCLXW N/A
  • WTFCP N/A
  • EPS
  • SCLXW N/A
  • WTFCP N/A
  • Revenue
  • SCLXW $55,152,000.00
  • WTFCP N/A
  • Revenue This Year
  • SCLXW N/A
  • WTFCP N/A
  • Revenue Next Year
  • SCLXW N/A
  • WTFCP N/A
  • P/E Ratio
  • SCLXW N/A
  • WTFCP N/A
  • Revenue Growth
  • SCLXW 22.02
  • WTFCP N/A
  • 52 Week Low
  • SCLXW $0.18
  • WTFCP N/A
  • 52 Week High
  • SCLXW $0.18
  • WTFCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • SCLXW N/A
  • WTFCP 19.68
  • Support Level
  • SCLXW N/A
  • WTFCP $25.25
  • Resistance Level
  • SCLXW N/A
  • WTFCP $25.39
  • Average True Range (ATR)
  • SCLXW 0.00
  • WTFCP 0.02
  • MACD
  • SCLXW 0.00
  • WTFCP -0.03
  • Stochastic Oscillator
  • SCLXW 0.00
  • WTFCP 3.00

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About WTFCP Wintrust Financial Corporation

Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.

Share on Social Networks: